Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Patient Education
Share your love
Naegis Pharma Funds Novel Eye Drug
Naegis Pharmaceuticals Inc., a life sciences company specializing in inflammation and ophthalmology, announced the successful closure of a financing round to advance its lead compound, N0651, towards a Phase 2 clinical trial. This funding will support the compound’s progression through…
Glaucoma Patients Miss Regular Eye Doctor Visits
In the August issue of Ophthalmology Epidemiology, a recently published study unveils a concerning trend among glaucoma patients. It was discovered that one-third of these patients ceased to visit their eye doctors for regular check-ups over a 10-year period. Conducted…
Glaucomatous Optic Neuropathy & Latest Treatments
Glaucomatous optic neuropathy is characterized by progressive loss of retinal ganglion cells (RGCs) and their axons and leads to measureable structural and functional damage to the optic nerve, visual impairment, and blindness. The primary site of injury is thought to be…
Pros and Cons of Laser Surgery for Glaucoma Patients
Glaucoma is a complex eye condition characterized by increased intraocular pressure, which can lead to damage to the optic nerve and vision loss if left untreated. This group of eye disorders often develops without noticeable symptoms in its early stages,…
Anterior Uveitis: Causes, Symptoms and Treatment
Picture this: You’re an astronaut on a space mission, and you’ve just stepped out of your spacecraft onto the surface of a mysterious new planet. Your eyesight is crucial to your survival in this alien environment, as you must rely…
Glaucoma Eye Drops List You Need for IOP Management
Glaucoma, a group of eye conditions that damage the optic nerve, is often linked to an increase in intraocular pressure (IOP). Managing IOP is crucial in glaucoma treatment to prevent vision loss. Eye drops play a vital role in this…
What Is Pseudoexfoliation Syndrome? | OBN
Pseudoexfoliation syndrome (PEX) is a systemic disorder characterized by the abnormal production and accumulation of fibrous extracellular material in various parts of the body, including the eyes. This condition is most commonly known for its impact on ocular health, where…
The Connection Between Antidepressants and Glaucoma
Amidst the intricate interplay of medical conditions and their treatments, unexpected relationships sometimes emerge. One such intriguing link has been proposed between antidepressant use and the risk of glaucoma. As two conditions seemingly distinct, depression and glaucoma occupy different corners…
Bausch + Lomb Launches ‘Faces of Glaucoma’ Campaign
Bausch + Lomb and the Glaucoma Research Foundation (GRF) have introduced the “Faces of Glaucoma” campaign, aiming to showcase a variety of patient stories and enhance awareness about the global issue of glaucoma, the second leading cause of blindness. This…
SpyGlass Pharma Secures $90M in Funding
SpyGlass Pharma has successfully closed a Series C financing round, raising $90 million. RA Capital Management led the funding round, joined by existing investors New Enterprise Associates (NEA) and Vensana Capital, as well as new investors Samsara BioCapital and Vertex…